Physician profile
Daniel Ventarola
NPI 1982091104
$4,696.56
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $2,475 · 2021: $614 · 2022: $458 · 2023: $334 · 2024: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,619.29 | 2019-2020 | |
| Kerecis Limited | $396.96 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Penumbra, INC. | $237.16 | 2021-2024 | Indigo System |
| Smith+Nephew, INC. | $213.64 | 2022-2024 | Grafix Pl, Pico, Renasys Go V2 Home |
| Shockwave Medical, INC | $210.00 | 2022 | |
| W. L. Gore & Associates, INC. | $191.26 | 2022-2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Endologix LLC | $166.45 | 2021 | |
| Philips North America LLC | $133.67 | 2023-2024 | (Dd1) Duo Hybrid |
| Medtronic, INC. | $133.56 | 2023-2024 | Abre, Closurefast |
| Cook Medical LLC | $109.13 | 2024 | Zenith Alpha |
| Silk Road Medical, INC. | $101.20 | 2021 | |
| Bioventus LLC | $79.14 | 2022 | |
| Integra Lifesciences Corporation | $44.01 | 2022 | |
| Reprise Biomedical, INC. | $24.28 | 2024 | Miro3d |
| Terumo Medical Corporation | $21.98 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bone Support INC. | $14.83 | 2024 | Ceramentbone Void Filler, Cerament G |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ventarola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.